Zapraszamy do pobrania materiałów wypracowanych w ramach projektu EUnetHTA JA3:
Raport dot. brolucizumabu w AMD (Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD))
Raport dot. sotagliflozyny w cukrzycy (Sotagliflozin for adult patients with Type 1 Diabetes Mellitus who have inadequate blood glucose control using insulin or insulin analogues)